Skip to content

Fat Taste Sensory Study

Fat Taste Sensory Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03540693
Acronym
FaTSS
Enrollment
105
Registered
2018-05-30
Start date
2018-04-06
Completion date
2023-07-06
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Bariatric Surgical Procedure

Keywords

Bariatric surgery, gastric bypass surgery, sleeve gastrectomy, laparoscopic gastric banding, food preferences, flavor perception

Brief summary

Fat is the most energy dense macronutrient and consuming fat has been positively correlated to obesity. Individuals afflicted with obesity crave fat more frequently, have a higher preference for fatty taste, and consume a higher quantity of fatty foods. People who have undergone Roux-en-Y Gastric Bypass (RYGB) or Sleeve Gastrectomy (SG) weight-loss surgeries dramatically decrease their fat preferences and consumption of fat, at least within the first year after surgery. These surgeries are very effective in helping people lose weight over the first couple of years; however, approximately 30% of those who undergo these surgeries start regaining weight after the second year mark. Why some people are able to keep the weight off long-term but others are unable to is unclear. In addition, it is well-known that fat can modify the flavor of foods and flavor plays a critical role in consumption, as well as in responses that gear up the body to consume the food. These are known as cephalic phase responses and include neural, physiological, and hormonal aspects. The main goals of the study are twofold: 1) To test the immediate effects of RYGB surgery, SG surgery, and laparoscopic gastric banding (LAGB) surgery (a weight loss control group) on fat preferences and sensory perception, and 2) to compare fat preferences and sensory perception between those who are able to achieve sustained weight loss 2-5 years after RYGB or SG surgery and those who either regained weight or did not lose the desired amount.

Detailed description

For the first goal, the investigators will assess a longitudinal group of subjects both before RYGB surgery (n=15) SG surgery (n=15), and LAGB surgery (n=15), and then again after they lose \ 16% of their body weight post-surgery in the fed and the fasted state. the investigators will also study the same variables in a cross-sectional design consisting of two groups: a weight success group (n=30) and a weight failure group (n=30) 2-5 years post RYGB or SG surgery. The weight success group will include subjects who lost ≥40% body weight by 2-5 years post-surgery and the weight failure group will include subjects who lost \<25% body weight by 2-5 years post-surgery. In addition, the investigators will also explore the extent to which fat preferences and sensory perception in these subjects are affected by flavor related genes.

Interventions

PROCEDURERYGB

RYGB-weight loss surgery

PROCEDURESG

SG- weight loss surgery

PROCEDURELAGB

LAGB- weight loss surgery

Sponsors

Carle Foundation Hospital
CollaboratorOTHER
University of Illinois at Urbana-Champaign
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Women and men, 18-64 years of age, all races * Subjects must be scheduled to undergo Roux-en-Y Gastric Bypass surgery (RYGB), Sleeve Gastrectomy surgery (SG), or laparoscopic gastric banding surgery (LAGB) and be available to be tested both pre- and post-surgery or must have undergone RYGB or SG surgery between 2-5 (i.e. at least two years ago and not more than 5) years ago and have a current weight loss that is ≥40% of body weight pre-surgery or \<25% of body weight pre-surgery.

Exclusion criteria

* Smoking tobacco related cigarettes or having quit smoking less than 6 months ago * Pregnant or breastfeeding * Are experiencing significant organ dysfunction * Take medications that could influence research results * Have any psychiatric illness or disorder that could influence compliance or completion of the study * History of chronic rhinitis * Had a diagnosis of or are taking medicine to treat diabetes * Inflammatory intestinal disease * Subjects who underwent RYGB or SG between 2-3 years ago and have a current weight loss that is \<40% and ≥25% of their body weight pre-surgery. * Subjects must find the taste of the food to be sham-fed acceptable (e.g. cream cheese, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Flavor perception3-6 monthsChanges in perception of flavor intensity in the general label magnitude scale (in mm)
Flavor preference3-6 monthsChanges in perception of hedonic value in the hedonic version of the general label magnitude scale (in mm)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026